A systematic review and meta-analysis of the efficacy of vonoprazan for proton pump inhibitor-resistant gastroesophageal reflux disease.

Daniel Martin SimadibrataElvira LesmanaRonnie Fass

Published in: Journal of gastroenterology and hepatology (2024)

Vonoprazan demonstrated high efficacy in the healing and maintenance of PPI-resistant EE and moderate efficacy for the improvement of FSSG score. Vonoprazan was well tolerated in PPI-resistant GERD patients.

Keyphrases

gastroesophageal reflux disease
helicobacter pylori
end stage renal disease
endoscopic submucosal dissection
ejection fraction
chronic kidney disease
peritoneal dialysis
protein protein
prognostic factors
small molecule